Stroke prevalence amongst sickle cell disease patients in Nigeria: a multi-centre study
: Background: Stroke is a life-changing, debilitating complication of sickle cell disease (SCD). Previous studies had recorded high stroke prevalence amongst this group of patients. Nigeria has a large population of people affected by this condition and this study aims to assess the stroke prevalenc...
Saved in:
Published in: | African health sciences Vol. 14; no. 2; pp. 446 - 452 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Uganda
Makerere University Medical School
01-06-2014
Makerere Medical School |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | : Background: Stroke is a life-changing, debilitating complication of
sickle cell disease (SCD). Previous studies had recorded high stroke
prevalence amongst this group of patients. Nigeria has a large
population of people affected by this condition and this study aims to
assess the stroke prevalence in this large population. Methodology:
Stroke prevalence data from 14 physicians working in 11 tertiary health
centres across the country was collated by doctors using the sickle
cell registers and patient case notes. This data was then collated and
used to obtain the overall stroke prevalence in adult and children.
Results: The stroke prevalence in sickle cell disease patients in
Nigeria was observed to be 12.4 per 1000 patients. Prevalence in the
adult patients was 17.7 per 1000 patients and 7.4 per 1000 patients in
children. Twenty three percent of the affected patients had more than
stroke episode. Conclusion: The stroke prevalence in Nigeria is lower
than previously recorded rates and further studies will be required to
investigate other factors which may play a role. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1680-6905 1729-0503 1680-6905 |
DOI: | 10.4314/ahs.v14i2.22 |